Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martin Javier San currently holds 350,000 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Javier San has been a net seller of ATHA stock. They have purchased $0 and sold $4.2M worth of shares.
Martin Javier San's most recent insider trade was on Apr 9, 2026, when they sold 350,000 shares at $0.00 per share.
Martin Javier San serves as Executive at Athira Pharma, Inc. (ATHA). They have executed 23 insider transactions totaling $4.2M over their tenure at the company.
Martin Javier San holds the position of Executive at Athira Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Martin Javier San has shown a selling trading pattern, with $0 in total purchases and $4.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Martin Javier San was on Nov 19, 2020, when they sold $1.4M worth of ARWR shares. This transaction involved 19,500 shares at $69.39 per share.
Martin Javier San currently owns 350,000 shares of Athira Pharma, Inc. (ATHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martin Javier San's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martin Javier San has 23 Form 4 filings on record as an insider at Athira Pharma, Inc..
Set alerts for Martin Javier San and 40,000+ other insiders.